BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang ZT, Yao YM, Xiao GX, Sheng ZY. Risk factors of development of gut-derived bacterial translocation in thermally injured rats. World J Gastroenterol 2004; 10(11): 1619-1624 [PMID: 15162536 DOI: 10.3748/wjg.v10.i11.1619] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Moludi J, Maleki V, Jafari‐vayghyan H, Vaghef‐mehrabany E, Alizadeh M. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics. Clin Exp Pharmacol Physiol 2020;47:927-39. [DOI: 10.1111/1440-1681.13250] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
2 Zhou QQ, Yang DZ, Luo YJ, Li SZ, Liu FY, Wang GS. Over-starvation aggravates intestinal injury and promotes bacterial and endotoxin translocation under high-altitude hypoxic environment. World J Gastroenterol 2011; 17(12): 1584-1593 [PMID: 21472125 DOI: 10.3748/wjg.v17.i12.1584] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
3 Patterson E, Marques TM, O'Sullivan O, Fitzgerald P, Fitzgerald GF, Cotter PD, Dinan TG, Cryan JF, Stanton C, Ross RP. Streptozotocin-induced type-1-diabetes disease onset in Sprague-Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity. Microbiology (Reading) 2015;161:182-93. [PMID: 25370749 DOI: 10.1099/mic.0.082610-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
4 Kondo S, Xiao JZ, Satoh T, Odamaki T, Takahashi S, Sugahara H, Yaeshima T, Iwatsuki K, Kamei A, Abe K. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci Biotechnol Biochem 2010;74:1656-61. [PMID: 20699581 DOI: 10.1271/bbb.100267] [Cited by in Crossref: 138] [Cited by in F6Publishing: 122] [Article Influence: 11.5] [Reference Citation Analysis]
5 Du Y, Gao XR, Peng L, Ge JF. Crosstalk between the microbiota-gut-brain axis and depression. Heliyon. 2020;6:e04097. [PMID: 32529075 DOI: 10.1016/j.heliyon.2020.e04097] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
6 Delzenne NM, Cani PD, Neyrinck AM. Prebiotics and Lipid Metabolism. In: Versalovic J, Wilson M, editors. Therapeutic Microbiology. Washington: ASM Press; 2008. pp. 183-92. [DOI: 10.1128/9781555815462.ch14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Delzenne NM, Neyrinck AM, Cani PD. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact. 2011;10 Suppl 1:S10. [PMID: 21995448 DOI: 10.1186/1475-2859-10-s1-s10] [Cited by in Crossref: 129] [Cited by in F6Publishing: 70] [Article Influence: 11.7] [Reference Citation Analysis]
8 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2006; 14(17): 1721-1725 [DOI: 10.11569/wcjd.v14.i17.1721] [Reference Citation Analysis]
9 An HM, Park SY, Lee do K, Kim JR, Cha MK, Lee SW, Lim HT, Kim KJ, Ha NJ. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis. 2011;10:116. [PMID: 21745411 DOI: 10.1186/1476-511x-10-116] [Cited by in Crossref: 170] [Cited by in F6Publishing: 79] [Article Influence: 15.5] [Reference Citation Analysis]
10 Pachikian BD, Neyrinck AM, Deldicque L, De Backer FC, Catry E, Dewulf EM, Sohet FM, Bindels LB, Everard A, Francaux M. Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J Nutr. 2010;140:509-514. [PMID: 20089787 DOI: 10.3945/jn.109.117374] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
11 Reber SO. Stress and animal models of inflammatory bowel disease--an update on the role of the hypothalamo-pituitary-adrenal axis. Psychoneuroendocrinology 2012;37:1-19. [PMID: 21741177 DOI: 10.1016/j.psyneuen.2011.05.014] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
12 Xiao SC, Zhu SH, Xia ZF, Lu W, Wang GQ, Ben DF, Wang GY, Cheng DS. Prevention and treatment of gastrointestinal dysfunction following severe burns: A summary of recent 30-year clinical experience. World J Gastroenterol 2008; 14(20): 3231-3235 [PMID: 18506931 DOI: 10.3748/wjg.14.3231] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
13 Zhang C, Zhang M, Pang X, Zhao Y, Wang L, Zhao L. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J. 2012;6:1848-1857. [PMID: 22495068 DOI: 10.1038/ismej.2012.27] [Cited by in Crossref: 254] [Cited by in F6Publishing: 236] [Article Influence: 25.4] [Reference Citation Analysis]
14 Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Yoshiya K, Matsushima A, Sumi Y, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60:126-133. [PMID: 16456446 DOI: 10.1097/01.ta.0000197374.99755.fe] [Cited by in Crossref: 146] [Cited by in F6Publishing: 133] [Article Influence: 9.1] [Reference Citation Analysis]
15 Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE, Barker LA, Breuel KF, Deponti WK, Kalbfleisch JH. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther. 2005;314:1079-1086. [PMID: 15976018 DOI: 10.1124/jpet.105.085415] [Cited by in Crossref: 206] [Cited by in F6Publishing: 189] [Article Influence: 12.1] [Reference Citation Analysis]
16 Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58:1091-1103. [PMID: 19240062 DOI: 10.1136/gut.2008.165886] [Cited by in Crossref: 1478] [Cited by in F6Publishing: 1379] [Article Influence: 113.7] [Reference Citation Analysis]
17 Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374-2383. [PMID: 17823788 DOI: 10.1007/s00125-007-0791-0] [Cited by in Crossref: 1080] [Cited by in F6Publishing: 989] [Article Influence: 72.0] [Reference Citation Analysis]
18 Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 2013;143:324-31. [PMID: 23303873 DOI: 10.3945/jn.112.166132] [Cited by in Crossref: 185] [Cited by in F6Publishing: 170] [Article Influence: 20.6] [Reference Citation Analysis]
19 Woting A, Pfeiffer N, Hanske L, Loh G, Klaus S, Blaut M. Alleviation of high fat diet-induced obesity by oligofructose in gnotobiotic mice is independent of presence of Bifidobacterium longum. Mol Nutr Food Res 2015;59:2267-78. [PMID: 26202344 DOI: 10.1002/mnfr.201500249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
20 Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104 Suppl 2:S1-S63. [PMID: 20920376 DOI: 10.1017/s0007114510003363] [Cited by in Crossref: 1186] [Cited by in F6Publishing: 393] [Article Influence: 98.8] [Reference Citation Analysis]
21 Carreras NL, Martorell P, Chenoll E, Genovés S, Ramón D, Aleixandre A. Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats. Beneficial Microbes 2018;9:629-41. [DOI: 10.3920/bm2017.0141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Wang YL, Zheng YJ, Zhang ZP, Su JY, Lei RQ, Tang YQ, Zhang SD. Effects of gut barrier dysfunction and NF-kappaB activation on aggravating mechanism of severe acute pancreatitis. J Dig Dis. 2009;10:30-40. [PMID: 19236545 DOI: 10.1111/j.1751-2980.2008.00360.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
23 He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci 2017;7:54. [PMID: 29090088 DOI: 10.1186/s13578-017-0183-1] [Cited by in Crossref: 117] [Cited by in F6Publishing: 100] [Article Influence: 23.4] [Reference Citation Analysis]
24 Manaer T, Yu L, Nabi XH, Dilidaxi D, Liu L, Sailike J. The beneficial effects of the composite probiotics from camel milk on glucose and lipid metabolism, liver and renal function and gut microbiota in db/db mice. BMC Complement Med Ther 2021;21:127. [PMID: 33888105 DOI: 10.1186/s12906-021-03303-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Delzenne NM, Cani PD. Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: Potential interest of prebiotics. International Dairy Journal 2010;20:277-80. [DOI: 10.1016/j.idairyj.2009.11.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
26 Chen J, Wang R, Li XF, Wang RL. Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. Br J Nutr. 2012;107:1429-1434. [PMID: 21914236 DOI: 10.1017/s0007114511004491] [Cited by in Crossref: 78] [Cited by in F6Publishing: 39] [Article Influence: 7.1] [Reference Citation Analysis]
27 Ávila PRM, Michels M, Vuolo F, Bilésimo R, Burger H, Milioli MVM, Sonai B, Borges H, Carneiro C, Abatti M, Santana IVV, Michelon C, Dal-pizzol F. Protective effects of fecal microbiota transplantation in sepsis are independent of the modulation of the intestinal flora. Nutrition 2020;73:110727. [DOI: 10.1016/j.nut.2020.110727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
28 Liu X, Chen Y, You B, Peng Y, Chen Y, Yang Z, Zhang Y, Chen J. Molecular mechanism mediating enteric bacterial translocation after severe burn: the role of cystic fibrosis transmembrane conductance regulator. Burns Trauma 2020;8:tkaa042. [PMID: 33501367 DOI: 10.1093/burnst/tkaa042] [Reference Citation Analysis]
29 de Goffau MC, Luopajärvi K, Knip M, Ilonen J, Ruohtula T, Härkönen T, Orivuori L, Hakala S, Welling GW, Harmsen HJ. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes. 2013;62:1238-1244. [PMID: 23274889 DOI: 10.2337/db12-0526] [Cited by in Crossref: 348] [Cited by in F6Publishing: 310] [Article Influence: 34.8] [Reference Citation Analysis]
30 Wang YB, Liu J, Yang ZX. Effects of intestinal mucosal blood flow and motility on intestinal mucosa. World J Gastroenterol 2011; 17(5): 657-661 [PMID: 21350716 DOI: 10.3748/wjg.v17.i5.657] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
31 Safavi M, Farajian S, Kelishadi R, Mirlohi M, Hashemipour M. The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial. Int J Food Sci Nutr. 2013;64:687-693. [PMID: 23477506 DOI: 10.3109/09637486.2013.775224] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
32 Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Molecular Aspects of Medicine 2013;34:39-58. [DOI: 10.1016/j.mam.2012.11.001] [Cited by in Crossref: 314] [Cited by in F6Publishing: 289] [Article Influence: 34.9] [Reference Citation Analysis]
33 Reber SO, Peters S, Slattery DA, Hofmann C, Schölmerich J, Neumann ID, Obermeier F. Mucosal immunosuppression and epithelial barrier defects are key events in murine psychosocial stress-induced colitis. Brain Behav Immun. 2011;25:1153-1161. [PMID: 21397685 DOI: 10.1016/j.bbi.2011.03.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
34 Bron PA, Kleerebezem M, Brummer RJ, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM. Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr 2017;117:93-107. [PMID: 28102115 DOI: 10.1017/S0007114516004037] [Cited by in Crossref: 170] [Cited by in F6Publishing: 91] [Article Influence: 34.0] [Reference Citation Analysis]
35 Wang LJ, Liu DY, Sun M, Zhao X. Effect of platelet activating factor on function of intestinal immunological barrier in young rats. Shijie Huaren Xiaohua Zazhi 2005; 13(18): 2266-2268 [DOI: 10.11569/wcjd.v13.i18.2266] [Reference Citation Analysis]
36 An J, Kang Q, Pan YM, Sun W, Wang X, Qi YJ. Clinical significance of HIF-1α expression in gastric malignant transformation in people from high altitude area of Qinghai. Shijie Huaren Xiaohua Zazhi 2017; 25(5): 404-411 [DOI: 10.11569/wcjd.v25.i5.404] [Reference Citation Analysis]
37 Bailey MT, Engler H, Sheridan JF. Stress induces the translocation of cutaneous and gastrointestinal microflora to secondary lymphoid organs of C57BL/6 mice. J Neuroimmunol. 2006;171:29-37. [PMID: 16253348 DOI: 10.1016/j.jneuroim.2005.09.008] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 5.1] [Reference Citation Analysis]
38 Liu H, Xu W, Yuan Y, Cao S, He X, Li S, Huang K, Luo Y. The effect of genetically modified Lactobacillus plantarum 590 on the gut health of sprague-dawley rats. IUBMB Life 2012;64:617-27. [DOI: 10.1002/iub.1027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care. 2007;10:729-734. [PMID: 18089955 DOI: 10.1097/mco.0b013e3282efdebb] [Cited by in Crossref: 200] [Cited by in F6Publishing: 88] [Article Influence: 14.3] [Reference Citation Analysis]
40 Luo H, Guo P, Zhou Q. Role of TLR4/NF-κB in damage to intestinal mucosa barrier function and bacterial translocation in rats exposed to hypoxia. PLoS One. 2012;7:e46291. [PMID: 23082119 DOI: 10.1371/journal.pone.0046291] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
41 Cani PD, Delzenne NM, Amar J, Burcelin R. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) 2008;56:305-9. [PMID: 18178333 DOI: 10.1016/j.patbio.2007.09.008] [Cited by in Crossref: 155] [Cited by in F6Publishing: 148] [Article Influence: 11.1] [Reference Citation Analysis]
42 Zhang JW, Zhang GX, Chen HL, Liu GL, Owusu L, Wang YX, Wang GY, Xu CM. Therapeutic effect of Qingyi decoction in severe acute pancreatitis-induced intestinal barrier injury. World J Gastroenterol 2015; 21(12): 3537-3546 [PMID: 25834318 DOI: 10.3748/wjg.v21.i12.3537] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
43 Ito H, Tanabe H, Kawagishi H, Tadashi W, Yasuhiko T, Sugiyama K, Kiriyama S, Morita T. Short-chain inulin-like fructans reduce endotoxin and bacterial translocations and attenuate development of TNBS-induced colitis in rats. Dig Dis Sci 2009;54:2100-8. [PMID: 19051017 DOI: 10.1007/s10620-008-0599-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
44 Balzan S, de Almeida Quadros C, de Cleva R, Zilberstein B, Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol 2007;22:464-71. [PMID: 17376034 DOI: 10.1111/j.1440-1746.2007.04933.x] [Cited by in Crossref: 212] [Cited by in F6Publishing: 204] [Article Influence: 14.1] [Reference Citation Analysis]
45 Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr. 2012;108:801-809. [PMID: 22717075 DOI: 10.1017/s0007114512001213] [Cited by in Crossref: 330] [Cited by in F6Publishing: 175] [Article Influence: 33.0] [Reference Citation Analysis]
46 Chen J, He X, Huang J. Diet effects in gut microbiome and obesity. J Food Sci 2014;79:R442-51. [PMID: 24621052 DOI: 10.1111/1750-3841.12397] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
47 Li M, Han T, Zhang W, Li W, Hu Y, Lee SK. Simulated altitude exercise training damages small intestinal mucosa barrier in the rats. J Exerc Rehabil 2018;14:341-8. [PMID: 30018916 DOI: 10.12965/jer.1835128.064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
48 Santos-Marcos JA, Perez-Jimenez F, Camargo A. The role of diet and intestinal microbiota in the development of metabolic syndrome. J Nutr Biochem. 2019;70:1-27. [PMID: 31082615 DOI: 10.1016/j.jnutbio.2019.03.017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 14.0] [Reference Citation Analysis]
49 Chen JJ, Wang R, Li XF, Wang RL. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Exp Biol Med (Maywood). 2011;236:823-831. [PMID: 21685239 DOI: 10.1258/ebm.2011.010399] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]